Dr. Alfredo E. Bruno (CEO)
In addition to directing the company, Dr. Bruno is responsible for patent writing and laser development. After completing his master of science degree in Computational Quantum Chemistry and earning his doctorate in Laser Physics at the University of Saskatchewan (Canada), Dr. Bruno went to Munich (Germany) to work on lasers as an Alexander von Humboldt Fellow at the Technical University of Munich. In 1988, he began working for Ciba-Geigy (now Novartis) and conducted a variety of research and development projects in collaboration with the American companies Spectra-Physics and Chiron Diagnostics. In 2004, he founded TLT Medical AG, an affiliate of Novartis. After selling TLT, he became the co-founder and CEO of FreiBiotics, an affiliate of the University of Freiburg (Germany,) which is a leader in the research of next-generation antibiotics. He has authored more than 50 scientific publications in his career, and holds over 15 patents.
Andreas Meschberger (CQM)
Andreas Meschberger is responsible for the areas of quality management and regulatory affairs. After his electrical engineering studies at the FHNW (University of Applied Sciences, Northwest Switzerland), Andreas Meschberger completed postgraduate studies in medical technology/biomedical technology at the NTB (University of Applied Sciences Buchs, Switzerland). He worked for more than 15 years as an electronics developer for medical devices and EMC test simulators. Additionally, he oversaw organizational development and IT for an SME. He was co-responsible for the development and accreditation of a calibration laboratory. Thereafter, Andreas Meschberger worked as a quality manager in medical technology for several years, during which time he became a certified quality manager in medical technology. Andreas Meschberger has extensive experience in the area of quality management, regulatory affairs and electronics and an NDS Business and Engineering Management degree from the FHNW. He worked in industry (EM, TEST, Sandoz) as well as in medtech companies (Stratec, Sentec). Andreas Meschberger is a member of the national standards committees “Electrical Devices in Medical Application” and ”Optical Radiation Safety and Laser Devices“.
Daniel Kronberger (CFO)
Daniel Kronberger is responsible for the areas of finance & controlling at AOT. He studied business administration at Vienna University of Economics and Business Administration (Austria). In addition, Mr. Kronberger holds a postgraduate diploma in internal relations from Johns Hopkins University, Bologna (Italy) and a master in finance & accounting from Macquarie University, Sydney (Australia). Daniel Kronberger has gained several years of work experience in industry, private equity and in consulting (among others Beiersdorf AG, Freudenberg Chemical Specialities as well as Deutsche Beteiligungs AG).
Cyrill C. Bätscher (COO)
Cyrill C. Baetscher is responsible for administration, marketing, sales, business development and project management at AOT. He holds an MBA from the State University of New York, Albany (USA), a BBA from the Graduate School for Business Administration in Zurich (Switzerland), and a degree in Mechanical Engineering from the Technical Institute of Northwestern Switzerland in Muttenz (Switzerland.) Mr. Bätscher has extensive managerial experience and know-how; both in the MedTech business (Stratec Medical, Synthes, Johnson & Johnson) as well as in the metalworking and consumer goods industry (Ringele AG, DoetschGrether AG).